Maxion Therapeutics

0 followers


Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.

Employees

11-50

Links


Org chart

Collapse
John Mccafferty
Co-founder And CTO
Sohaib Mir
Senior Investment Principal
Aneesh Karatt Vellatt
Chief Scientific Officer, Board Director
Sylwia Mankowska
Director Of Operations
Lucy Edwardes Jones
Board Director

Teams

This company has no teams yet